The effects of Berberis vulgaris L. and Berberis aristata L. in metabolic syndrome patients: a systematic and meta-analysis study

Abstract

Introduction

This meta-analysis study assessed the effects of Berberis vulgaris L. and Berberis aristata L. in patients with metabolic syndrome

Methods

Data were analysed through “random-effects meta-regression” performance

Results

The findings indicated that LDL was 0.68 and 2.92 lower in the B. vulgaris L. and B. aristata L.-treated groups versus the controls. The HDL was 0.71-fold higher in the B. aristata L.-treated group versus the controls. The total-cholesterol levels were 1.02 and 2.25 folds lower in the B. vulgaris L. and B. aristata L.-treated groups versus the matched control groups. The triglyceride levels were 1.35 and 1.16-fold lower in the B. vulgaris L. and B. aristata L.-treated groups versus the controls. Glucose was 0.96 and 0.54 folds lower in the B. vulgaris L. and B. aristata L.-treated groups versus the control groups, respectively

Conclusion

B. vulgaris L. and B. aristata L. have beneficial effects in patients with metabolic syndrome.

Keywords:

• Berberis aristata L.
• Berberis vulgaris L.
• metabolic syndrome

Author contributions

Manuscript conception and design by BR and SS. Data extraction and screening eligibility by all authors. Writing the drafted format of the manuscript by BR, TF, and SS. Critical revision by SS. All authors approved the final version of the manuscript for publication.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author (Saeed Samarghandian) upon reasonable request.